KAYS closes additional $600K non-dilutive bridge financing for Oregon psilocybin center

Kaya Holdings, Inc.

Total bridge financing since June 2023 is $600K: $100K short-term due Mar 15, 2023, $500K repayable from 10% of quarterly revenues, balance due Jun 30, 2025.
Funds are non-dilutive, not convertible into stock, and carry no commissions or fees.
Company expects to submit Oregon Health Authority license application in 30 days and open The Sacred Mushroom facility within 90 days of approval.
The 11,000 sq ft facility will include a microdosing café, private treatment rooms, group areas, and activity zones aiming for lower pricing than competitors.
KAYS believes it is the only U.S. public company pursuing an OHA psilocybin treatment center license.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.